1 active not recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Hemarthrosis: new trials by email Literature Review of Hemarthrosis trials Research Report on Hemarthrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Real-World Joint Outcomes After Selective Transition to Low-Dose Emicizumab in Pediatric Hemophilia A Switching to low dose emicizumab - Hemophilia A Patient | Phase 2 / Phase 3 | Active not recruiting | Chulalongkorn University | 18 | 2025-06-01 | 2026-02-27 |
Hemophilia A (1)
Blood Coagulation Disorders (1) · Blood Coagulation Disorders, Inherited (1) · Coagulation Protein Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhage (1) · Hemorrhagic Disorders (1) · Joint Diseases (1) · Musculoskeletal Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
emicizumab (1)
Thailand (1)